全文获取类型
收费全文 | 2092篇 |
免费 | 147篇 |
国内免费 | 36篇 |
专业分类
耳鼻咽喉 | 22篇 |
儿科学 | 105篇 |
妇产科学 | 65篇 |
基础医学 | 188篇 |
口腔科学 | 67篇 |
临床医学 | 213篇 |
内科学 | 381篇 |
皮肤病学 | 21篇 |
神经病学 | 165篇 |
特种医学 | 207篇 |
外科学 | 263篇 |
综合类 | 51篇 |
预防医学 | 228篇 |
眼科学 | 17篇 |
药学 | 135篇 |
中国医学 | 2篇 |
肿瘤学 | 145篇 |
出版年
2021年 | 27篇 |
2020年 | 17篇 |
2019年 | 21篇 |
2018年 | 31篇 |
2017年 | 20篇 |
2016年 | 32篇 |
2015年 | 32篇 |
2014年 | 48篇 |
2013年 | 67篇 |
2012年 | 88篇 |
2011年 | 81篇 |
2010年 | 62篇 |
2009年 | 61篇 |
2008年 | 63篇 |
2007年 | 87篇 |
2006年 | 77篇 |
2005年 | 68篇 |
2004年 | 64篇 |
2003年 | 59篇 |
2002年 | 58篇 |
2001年 | 42篇 |
2000年 | 54篇 |
1999年 | 67篇 |
1998年 | 45篇 |
1997年 | 46篇 |
1996年 | 52篇 |
1995年 | 43篇 |
1994年 | 46篇 |
1993年 | 37篇 |
1992年 | 47篇 |
1991年 | 45篇 |
1990年 | 36篇 |
1989年 | 60篇 |
1988年 | 58篇 |
1987年 | 51篇 |
1986年 | 40篇 |
1985年 | 33篇 |
1984年 | 27篇 |
1983年 | 25篇 |
1982年 | 22篇 |
1981年 | 19篇 |
1980年 | 20篇 |
1979年 | 21篇 |
1978年 | 19篇 |
1976年 | 23篇 |
1975年 | 20篇 |
1974年 | 24篇 |
1971年 | 27篇 |
1970年 | 20篇 |
1969年 | 19篇 |
排序方式: 共有2275条查询结果,搜索用时 15 毫秒
61.
In two previous studies, we observed that recombinant human interleukin- 3 (IL-3) induced an increase in marrow burst-forming unit-erythroid- derived colonies in vitro in some patients with Diamond-Blackfan anemia (DBA). To determine whether a similar erythropoietic response could be induced in vivo, we treated 13 patients with DBA (aged 4 to 19 years) with two preparations of IL-3. All patients had absent absolute reticulocyte counts and markedly reduced to absent recognizable bone marrow erythroid elements; patients with circulating reticulocytes in the previous 12 months were excluded from study. All patients except 1 had failed steroid therapy and had been transfusion-dependent since infancy; 1 patient was maintained on high-dose prednisone at the time of enrollment. On the first arm of the study, IL-3 (Immunex Corp, Seattle, WA) was administered subcutaneously using a dose escalation regimen of 125 to 500 micrograms/m2/day in divided dosage at 12-hour intervals, coadministered with 1.5 mg/kg/d of oral ferrous sulphate. Of the 13 patients that entered the trial, 4 stopped prematurely because of adverse side effects. In the other 9 evaluable cases, reticulocytes increased transiently in 1 patient from 0 to 65 x 10(9)/L after 35 days of IL-3 therapy at 250 micrograms/m2, but transfusion dependency persisted. One transient peak in absolute reticulocyte count was noted in 6 other patients, but no erythroid response was observed after completion of a full course of IL-3. Oral prednisone at 0.5 mg/kg/d was then coadministered with IL-3 at 500 micrograms/m2 to 5 of the patients without effect, and treatment was stopped. In 2 patients, a second preparation of IL-3 (Sandoz Canada Inc, Dorval, Quebec, Canada) was initiated in a dose escalation regimen of 2.5 to 10 micrograms/kg and was coadministered with ferrous sulphate. No erythroid response was observed in either patient, and in one of the two, alternate-day subcutaneous recombinant erythropoietin at 300 U/kg was administered for 3 weeks in combination with daily IL-3 at 10 micrograms/kg, but no increased erythropoiesis was seen. Significant increases in white blood cell and eosinophil counts during administration of both preparations of IL-3 were observed in all patients. These data show that the response of DBA patients to IL-3 in vivo is heterogeneous and cannot be predicted from in vitro studies. The absence of a corrective effect of IL-3 in these patients with DBA indicates that a deficiency of the cytokine is not central in the pathogenesis of the disorder. 相似文献
62.
To clarify the defective erythropoiesis in eight patients with Diamond- Blackfan anemia, we studied their bone marrow response in vitro to recombinant human interleukin-3 (IL-3) and recombinant granulocyte- macrophage colony-stimulating factor (GM-CSF). In an erythropoietin- containing assay system, specimens from six of the eight patients yielded low numbers of erythroid colonies compared to control values, and in five of these no erythropoietin dose-response could be elicited. Addition of IL-3, GM-CSF or both to cultures from the six patients had no effect on CFU-E-derived colonies. In contrast, IL-3 but not GM-CSF induced a marked increase in the number (183%) and size of the BFU-E- derived colonies in five of the six cases and partially corrected the impaired dose-response to erythropoietin in four. Bone marrow from the other two patients yielded numbers of CFU-E and BFU-E colonies comparable to controls and manifested similar increments in colonies with increasing concentrations of erythropoietin. When IL-3 was added to these cultures, further increments were observed in the number and size of BFU-E colonies. We conclude that IL-3 enhanced the marrow erythropoiesis in most of the patients and exerted a corrective effect on the aberrant colony formation in the presence of erythropoietin. The data raise the possibility of IL-3 as a therapeutic agent in Diamond- Blackfan anemia. 相似文献
63.
64.
65.
Aaron M. Samuels Elizabeth Matey Pauline N. M. Mwinzi Ryan E. Wiegand Geoffrey Muchiri Edmund Ireri Molly Hyde Susan P. Montgomery Diana M. S. Karanja W. Evan Secor 《The American journal of tropical medicine and hygiene》2012,87(5):874-882
Schistosomiasis control programs aim to reduce morbidity but are evaluated by infection prevalence and intensity reduction. We present baseline cross-sectional data from a nested cohort study comparing indicators of morbidity for measuring program impact. Eight hundred twenty-two schoolchildren 7–8 years of age from Nyanza Province, Kenya, contributed stool for diagnosis of Schistosoma mansoni and soil-transmitted helminths (STH) and blood smears for malaria, and were evaluated for anemia, quality of life, exercise tolerance, anthropometry, and ultrasound abnormalities. Schistosoma mansoni, STH, and malaria infection prevalence were 69%, 25%, and 8%, respectively. Only anemia and S. mansoni infection (adjusted odds ratio [aOR] = 1.70; confidence interval [CI] = 1.03–2.80), and hepatomegaly and heavy S. mansoni infection (aOR = 2.21; CI = 1.19–4.11) were associated. Though anemia and hepatomegaly appeared most useful at baseline, additional morbidity indicators may be sensitive longitudinal measures to evaluate schistosomiasis program health impact. 相似文献
66.
67.
68.
Z Khalpey MH Yacoub RT Smolenski 《Annals of the Royal College of Surgeons of England》2013,95(1):9-14
Introduction
Human donor organ shortages have led surgeons and scientists to explore the use of animals as alternative organ sources. Acute thrombovascular rejection (AVR) is the main hurdle in xenotransplantation. Disparities in nucleotide metabolism in the vessels of different species may contribute significantly to the microvascular component of AVR.Methods
We evaluated the extent of nucleotide metabolism mismatch in selected organs and endothelial cells of different mammals with particular focus on the changes in activity of ecto-5’-nucleotidase (E5’N) elicited by exposure of porcine hearts or endothelial cells to human blood (ex vivo) or human plasma (in vitro).Results
E5’N activity in the rat heart was significantly higher than in other species. We noted a significant difference (p<0.001) in E5’N activity between human and pig endothelial cell lines. Initial pig aortic endothelial E5’N activity decreased in vitro after a three-hour exposure to human and porcine plasma while remaining constant in controls. Ex vivo perfusion with fresh human blood for four hours resulted in a significant decrease of E5’N activity in both wild type and transgenic pig hearts overexpressing human decay accelerating factor (p<0.001).Conclusions
This study provides evidence that mismatches in basal mammalian metabolic pathways and humoral immunity interact in a xenogeneic environment. Understanding the role of nucleotide metabolism and signalling in xenotransplantation may identify new targets for genetic modifications and may lead to the development of new therapies extending graft survival. 相似文献69.
DC Bosanquet CN Jones N Gill P Jarvis MH Lewis 《Annals of the Royal College of Surgeons of England》2013,95(1):15-19
Introduction
Numerous strategies are employed routinely in an effort to lower rates of surgical site infections (SSIs). A laminar flow theatre environment is generally used during orthopaedic surgery to reduce rates of SSIs. Its role in vascular surgery, especially when arterial bypass grafts are used, is unknown.Methods
A retrospective review of a prospectively maintained database was undertaken for all vascular procedures performed by a single consultant over a one-year period. Cases were performed, via random allocation, in either a laminar or non-laminar flow theatre environment. Demographic data, operative data and evidence of postoperative SSIs were noted. A separate subgroup analysis was undertaken for patients requiring an arterial bypass graft. Univariate and multivariate logistical regression was undertaken to identify significant factors associated with SSIs.Results
Overall, 170 procedures were analysed. Presence of a groin incision, insertion of an arterial graft and a non-laminar flow theatre were shown to be predictive of SSIs in this cohort. In the subgroup receiving arterial grafts, only a non-laminar flow theatre environment was shown to be predictive of an SSI.Conclusions
This study suggests that laminar flow may reduce incidences of SSI, especially in the subgroup of patients receiving arterial grafts. 相似文献70.